论文部分内容阅读
目的研究标准桃金娘油胶囊联合舒利迭治疗慢性阻塞性肺疾病急性加重期(AECOPD)的疗效。方法将2013年1月至2014年1月解放军第148心医院呼吸科选择的60例AECOPD患者随机分为治疗组和对照组各30例。治疗组患者在常规治疗的基础上加用标准桃金娘油胶囊(300 mg口服每日3次,德国希尔制药)联合舒利迭(50μg/500μg,葛兰素史克公司)每次1吸,每日2次治疗。结果治疗组和对照组总的有效率分别为76.7%、90.3%,两组疗效比较差异有统计学意义(P<0.05)。结论标准桃金娘油胶囊联合舒利迭治疗能明显改善AECOPD患者的临床症状及改善预后。
Objective To study the efficacy of standard myrtle oil capsules combined with seretide in treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods Sixty AECOPD patients selected from Respiratory Department of the 148th Hospital of PLA from January 2013 to January 2014 were randomly divided into treatment group (n = 30) and control group (n = 30). Patients in the treatment group were treated with standard myrtle oil capsules (300 mg orally three times per day, Germany Hill Pharmaceutical Co., Ltd.) combined with seretide (50 μg / 500 μg, GlaxoSmithKline) on a routine basis for 1 inhalation , 2 times a day treatment. Results The total effective rates of the treatment group and the control group were 76.7% and 90.3%, respectively, with significant differences between the two groups (P <0.05). Conclusion Standard myrtle oil capsules combined with seretide treatment can significantly improve the clinical symptoms and improve the prognosis of patients with AECOPD.